Tags: Cancer | nipple | fluid | test | breast | cancer | fda

Common Breast Cancer Test Is Ineffective, FDA Warns

Thursday, 12 Dec 2013 04:37 PM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
A nipple fluid test is not an effective screening tool for breast cancer, U.S. regulators warned on Thursday, noting that mammography is the best way to detect the disease in its earliest, most treatable stages.

The Food and Drug Administration, in a statement to healthcare professionals, said it is concerned that women will believe misleading claims about a nipple aspirate test and not get mammograms or other needed breast imaging tests or biopsies.
 
The agency noted that it had issued a warning letter earlier this year to Atossa Genetics Inc about its nipple aspirate fluid collection device and process. The company recalled the product in October.

The FDA said it is not aware of any valid scientific data to show that nipple aspirate testing by itself is an effective screening tool for any medical condition.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Comments
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
 
Find Your Condition
You May Also Like
Around the Web

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

NEWSMAXHEALTH.COM
© Newsmax Media, Inc.
All Rights Reserved